By Luis Suarez-Villa
Addresses the facility of oligopolistic firms in modern society.
the biggest, wealthiest enterprises have received extraordinary strength and impression in modern existence. From cradle to grave the selections made via those entities have an huge, immense impression on how we are living and paintings, what we consume, our actual and mental health and wellbeing, what we all know or think, whom we choose, and the way we deal with each other and with the flora and fauna round us. whilst, executive turns out ever extra subservient to the ability of those oligopolies, supplying a variety of types of company welfare—tax breaks, subsidies, promises, and bailouts—while neglecting the main simple wishes of the inhabitants. In Corporate strength, Oligopolies, and the hindrance of the State, Luis Suarez-Villa employs a multidisciplinary viewpoint to supply exceptional documentation of a starting to be situation of governance, marked by means of an incredible move of hazard from the non-public quarter to the nation, skyrocketing debt, nice inequality and monetary lack of confidence, besides an alignment of the pursuits of politicians and a brand new, minuscule yet immensely filthy rich and influential company elite. due to this dysfunctional setting, Suarez-Villa argues, stagnation and a vanishing public belief have develop into the hallmarks of our time.
“Suarez-Villa … has played a good carrier with this readable, analytical, and well-researched booklet … it is a must-order publication for libraries … hugely recommended.” — CHOICE
“This ebook makes a considerable contribution to the literature, rather to the sphere of political financial system. it truly is specified and masses wanted for how it attracts hyperlinks among a large and assorted variety of social, monetary, and political phenomena via a subtle and strong theoretical research. Luis Suarez-Villa manages to paint the massive photo whereas touching upon targeted advancements in different fields—not not like the nice political economists of the 19th century.” — Joel Bakan, writer of The company: The Pathological Pursuit of revenue and Power
Read Online or Download Corporate Power, Oligopolies, and the Crisis of the State PDF
Similar government & business books
This quantity is the results of a learn software, began on the international financial institution, that introduced jointly researchers from many backgrounds, together with participants from the transition economies. The paintings used to be supported through the area Bank's learn Committee and through the industrial improvement Institute. the implications pronounced the following make clear the standards that confirm the form and velocity of the transition from deliberate to industry economies.
Eco-innovation is extra vital than ever at the public coverage schedule. it's a significant motive force for eco-friendly development and contributes to the environmental functionality and financial improvement of OECD and constructing international locations alike. This document takes a practical method of rules that help the improvement and diffusion of eco-innovation.
Domestic to the world's so much complicated scientific practices, the U.S. spends extra on future health care than the other nation. whilst, therapy is tougher to get within the usa than in such a lot different industrialized countries. Benchmark data reminiscent of youngster mortality and existence expectancy demonstrate a society that isn't approximately as fit because it might be.
US President Barack Obama has known as monetary inequality the “defining factor of our time. ” It has encouraged the “Occupy” pursuits, made a French economist right into a international star, and given us a brand new expression – the “one percentage. ” yet is our preoccupation with inequality fairly justified? Or clever? In his new ebook, William Watson argues that targeting inequality is either an mistakes and a catch.
- Linking health and education for African American students' success
- A Prelude to the Foundation of Political Economy: Oil, War, and Global Polity
- The Organization of American States (Global Organizations)
- Punishment for Sale: Private Prisons, Big Business, and the Incarceration Binge
Extra info for Corporate Power, Oligopolies, and the Crisis of the State
Cox (accessed November 27, 2011). â•‡ Jessica E. Vascellaro, “Comcast Tests Tech Overhaul,” Wall Street Journal, May 26, 2011, B1. â•‡Martin Peers, John Jannarone, and Kate Linebaugh, “Comcast Buys Rest of NBC’s Parent,” Wall Street Journal, February 13, 2013, A1; “Comcast’s Future: Thinking Outside the Set‑Top Box—America’s Largest Cable Company Is Becoming More Like the Firms It Is Battling Against for the Attention of Couch Potatoes,” The Economist, December 14, 2013, 69–70. Further consolidation among other cable television oligopolists seems likely, as they try to imitate Comcast and expand their power over related media sectors; see Shalini Ramachandran, Dana Cimilluca, and Brent Kendall, “Rivals Eye Deal for No.
In this way, the lowering of diagnostic thresholds also creates new problems through negative side effects and damage—that in turn require further treatment and medications—thus increasing sales and profit for the oligopolistic corporations that now control American health care. In mental health care, an area that has been a growing source of profits for the pharmaceutical oligopolists, overdiagnosing and widespread prescribing have also taken root. â•‡H. Gilbert Welch, Lisa Schwartz, and Steven Woloshin, Overdiagnosed: Making People Sick in the Pursuit of Health (Boston: Beacon Press, 2011); H.
See David Healy, The Creation of Psychopharmacology (Cambridge: Harvard University Press, 2002). â•‡See, for example, Ron Grossman, “Psychiatry Manual’s Secrecy Criticized,” Los Angeles Times, December 29, 2008, A19; Shari Roan, “Psychiatric Diagnoses Get a Rethinking,” Los Angeles Times, May 22, 2011, A27; “Psychiatric Diagnosis: That Way, Madness Lies; A New Manual for Diagnosing Diseases of the Psyche Is about to Be Unveiled,” The Economist, February 6, 2010, 88. â•‡ See “The Pharmaceutical Industry: The Bitterest Pill,” The Economist, January 26, 2009, 62–63, and “Cliffhanger: Big Pharma Struggles to Protect Its Blockbusters as They Lose Patent Protection,” The Economist, December 3, 2011, 76.